DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Hycomine (Hydrocodone Bitartrate / Chlorpheniramine Maleate / Phenylephrine Hydrochloride / Acetaminophen / Caffeine) - Summary

 

-- advertisement --

HYCOMINE SUMMARY

HYCOMINE Compound tablets contain hydrocodone (dihydrocodeinone) bitartrate, a semi-synthetic centrally-acting opioid antitussive; chlorpheniramine maleate, an antihistamine; phenylephrine hydrochloride, a sympathomimetic amine decongestant; acetaminophen, an analgesic/antipyretic; and caffeine, a centrally-acting stimulant, for oral administration.

HYCOMINE Compound is indicated for the symptomatic relief of cough, nasal congestion, and discomfort associated with upper respiratory tract infections.

HYCOMINE NEWS HIGHLIGHTS

Clinical Trials Related to Hycomine (Hydrocodone / Chlorpheniramine / Phenylephrine / Acetaminophen / Caffeine)

Assessment and Treatment of Caffeine Dependence [Recruiting]

The Impact of Caffeine on Brachial Endothelial Function in Healthy Subjects and in Patients With Ischemic Heart Disease [Recruiting]

Caffeine for Excessive Daytime Somnolence in Parkinson's Disease [Recruiting]

Experimental Studies of the Effects of Caffeine on Glucose Regulation [Completed]

Effects of Low Doses of Caffeine on Mood, Physiology and Mental Function [Completed]

more>>

Page last updated: 2006-04-20

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008